{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:44Z","timestamp":1789146824968,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503714"],"award-info":[{"award-number":["82503714"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M763330"],"award-info":[{"award-number":["2024M763330"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQN26H160021"],"award-info":[{"award-number":["LQN26H160021"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.lungcan.2026.109601","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:12:16Z","timestamp":1788221536000},"page":"109601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging"],"prefix":"10.1016","volume":"220","author":[{"given":"Mengzhen","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7102-7283","authenticated-orcid":false,"given":"Cien","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1120-241X","authenticated-orcid":false,"given":"Li","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2115-7151","authenticated-orcid":false,"given":"Yalun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6123-0959","authenticated-orcid":false,"given":"Jianfei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-3385","authenticated-orcid":false,"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.lungcan.2026.109601_b0005","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa2502931","article-title":"Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer","volume":"393","author":"Forde","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109601_b0010","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical Trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109601_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s43018-025-01104-z","article-title":"Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis","volume":"7","author":"Provencio","year":"2026","journal-title":"Nat Cancer."},{"issue":"5","key":"10.1016\/j.lungcan.2026.109601_b0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cllc.2025.04.004","article-title":"Prognostic implications of lymph node status in non-small-cell lung cancer patients before and after neoadjuvant chemoimmunotherapy: a multicenter retrospective study","volume":"26","author":"Ma","year":"2025","journal-title":"Clin. Lung Cancer"},{"issue":"15","key":"10.1016\/j.lungcan.2026.109601_b0025","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.7150\/jca.119881","article-title":"The prognostic value of lymph node downstaging following neoadjuvant chemoimmunotherapy for non-small cell lung cancer","volume":"16","author":"Guo","year":"2025","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.lungcan.2026.109601_b0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jtho.2020.01.005","article-title":"IASLC multidisciplinary recommendations for pathologic assessment of lung cancer resection specimens after neoadjuvant therapy","volume":"15","author":"Travis","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109601_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107401","article-title":"Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"186","author":"Huang","year":"2023","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109601_b0040","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.21037\/jtd-24-1011","article-title":"Pathological responses of primary tumor and lymph nodes in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: a retrospective real-world study","volume":"16","author":"Shao","year":"2024","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109601_b0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ejcts\/ezaa290","article-title":"Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy","volume":"59","author":"Corsini","year":"2021","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109601_b0050","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1245\/s10434-018-6471-0","article-title":"Nodal downstaging in gastric cancer patients: promising survival if ypN0 is achieved","volume":"25","author":"Ikoma","year":"2018","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2026.109601_b0055","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/DCR.0000000000003846","article-title":"Nodal downstaging in patients with rectal cancer: survival is promising if YpN0 is achieved","volume":"68","author":"Wan","year":"2025","journal-title":"Dis. Colon Rectum"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109601_b0060","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11605-019-04317-7","article-title":"Nodal downstaging of esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: survival analysis if ypN0 is achieved","volume":"24","author":"Tang","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.lungcan.2026.109601_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104670","article-title":"Nodal response to neoadjuvant therapy predicts prognosis of breast cancer patients with clinically positive internal mammary nodes","volume":"85","author":"Xu","year":"2026","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109601_b0070","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(13)70334-6","article-title":"Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint","volume":"15","author":"Hellmann","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2026.109601_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104265","article-title":"Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"84","author":"Yang","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109601_b0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40164-023-00401-6","article-title":"\u201cMajor pathologic response\u201d in lymph nodes: a modified nodal classification for non-small cell lung cancer patients treated with neoadjuvant immunochemotherapy","volume":"12","author":"Deng","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109601_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.20517\/jtgg.2025.107","article-title":"Commentary: understanding acquired resistance to immunotherapy in non-small cell lung cancer","volume":"10","author":"Din","year":"2026","journal-title":"J Translational Genetics and Genomics"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109601_b0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1515\/jtim-2025-0047","article-title":"Protocol for Chinese lung cancer evolution and microenvironment tracking under therapy study","volume":"13","author":"Wang","year":"2025","journal-title":"J Transl Int Med."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109601_b0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1515\/jtim-2026-0023","article-title":"Molecular residual disease-based novel modality of postoperative management for non-small-cell lung cancer (REMODEL): protocol for a prospective multicenter study","volume":"14","author":"Yuan","year":"2026","journal-title":"J Transl Int Med."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109601_b0100","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"19","key":"10.1016\/j.lungcan.2026.109601_b0105","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.lungcan.2026.109601_b0110","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109601_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ejcts\/ezag028","article-title":"A subgroup analysis of perioperative pembrolizumab in clinical stage II non-small-cell lung cancer from the randomized KEYNOTE-671 study","volume":"68","author":"Tsuboi","year":"2026","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2026.109601_b0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jtho.2024.09.1443","article-title":"Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis","volume":"20","author":"Marinelli","year":"2025","journal-title":"J. Thorac. Oncol."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226006628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:55:26Z","timestamp":1789145726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226006628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0169500226006628"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109601","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant immunotherapy in resectable non-small cell lung cancer with nodal downstaging","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109601","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109601"}}